Status:
UNKNOWN
Pneumothorax After CT-guided Lung Biopsy: Standard vs Autologous Blood Patching
Lead Sponsor:
Humanitas Clinical and Research Center
Conditions:
Pneumothorax
Biopsy Wound
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The aim of this prospective, randomized study is to compare the rate of postoperative pneumothorax between standard CT-guided core needle biopsy (CNB) versus CNB followed by autologous blood patch inj...
Detailed Description
Pneumothorax is the most common complication of percutaneous lung biopsies. Reducing this risk is a goal of those who perform these procedures, particularly a reduction in large pneumothoraces requiri...
Eligibility Criteria
Inclusion
- All patients scheduled for lung biopsy will be asked to join this study. After signing the informed consent the subject will be randomized for ABPI vs CNB approach.
- Inclusion criteria:
- 1\) patients with pulmonary nodule requiring CT-guided lung biopsy.
- Exclusion criteria:
- unfit for lung biopsy (INR \>1.5, PLT \<50.000, single lung);
- unavailable venous access.
Exclusion
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03804957
Start Date
January 1 2019
End Date
April 1 2020
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Humanitas Research Hospital
Rozzano, Lombardy, Italy, 20089